6171 — CE Management Integrated Laboratory Co Income Statement
0.000.00%
Last trade - 00:00
- ¥5bn
- ¥3bn
- ¥7bn
- 89
- 83
- 58
- 94
2019 December 31st | 2020 December 31st | 2021 December 31st | C2022 December 31st | 2023 December 31st | |
---|---|---|---|---|---|
Period Length: | 12 M | 12 M | 12 M | 12 M | 12 M |
Source: | Yuho | Yuho | Yuho | Yuho | Yuho |
Standards: | JAS | JAS | JAS | JAS | JAS |
Status: | Final | Final | Final | Final | Final |
Revenue | |||||
Total Revenue | 6,066 | 6,208 | 7,341 | 6,999 | 7,327 |
Cost of Revenue | |||||
Gross Profit | 1,964 | 2,050 | 2,535 | 2,653 | 2,736 |
Selling / General / Administrative Expenses | |||||
Depreciation and Amortization | |||||
Unusual Expense / Income | |||||
Other Operating Expenses | |||||
Total Operating Expenses | 5,645 | 5,756 | 7,002 | 6,476 | 6,966 |
Operating Profit | 421 | 452 | 339 | 523 | 360 |
Total Net Non Operating Interest Income / Expense | |||||
Other Net Non Operating Costs | |||||
Net Income Before Taxes | 460 | 477 | 444 | 554 | 375 |
Provision for Income Taxes | |||||
Net Income After Taxes | 306 | 293 | 213 | 350 | 190 |
Net Income Before Extraordinary Items | |||||
Net Income | 306 | 293 | 213 | 350 | 190 |
Adjustments to Net Income | |||||
Income Available to Common Shareholders Excluding Extraordinary Items | |||||
Income Available to Common Shareholders Including Extraordinary Items | |||||
Diluted Net Income | 306 | 293 | 213 | 350 | 190 |
Diluted Weighted Average Shares | |||||
Basic EPS Including Extraordinary Items | |||||
Diluted EPS Including Extraordinary Items | |||||
Diluted EPS Excluding Extraordinary Items | |||||
Normalised Income Before Taxes | |||||
Normalised Income After Taxes | |||||
Normalised Income Available to Common Shareholders | |||||
Diluted Normalised EPS | 24.5 | 19 | 25.2 | 31.4 | 24.1 |
Dividends per Share |